Hereditary Hypercalcemia Caused by a Homozygous Pathogenic Variant in the CYP24A1 Gene: A Case Report and Review of the Literature
Introduction. Loss of function mutations of CYP24A1 gene, which is involved in vitamin D catabolism, cause vitamin D-mediated PTH-independent hypercalcemia. The phenotype varies from life-threatening forms in the infancy to milder forms in the adulthood. Case Presentation. We report a case of a 17-y...
Main Authors: | , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2019-01-01
|
Series: | Case Reports in Endocrinology |
Online Access: | http://dx.doi.org/10.1155/2019/4982621 |
id |
doaj-9feecd423ffa416dbd16164f771ef90c |
---|---|
record_format |
Article |
spelling |
doaj-9feecd423ffa416dbd16164f771ef90c2020-11-24T21:50:08ZengHindawi LimitedCase Reports in Endocrinology2090-65012090-651X2019-01-01201910.1155/2019/49826214982621Hereditary Hypercalcemia Caused by a Homozygous Pathogenic Variant in the CYP24A1 Gene: A Case Report and Review of the LiteratureDaniele Cappellani0Alessandro Brancatella1Martin Kaufmann2Angelo Minucci3Edda Vignali4Domenico Canale5Elisa De Paolis6Ettore Capoluongo7Filomena Cetani8Glenville Jones9Claudio Marcocci10Department of Clinical and Experimental Medicine, Unit of Endocrinology, University of Pisa, Pisa, ItalyDepartment of Clinical and Experimental Medicine, Unit of Endocrinology, University of Pisa, Pisa, ItalyDepartment of Biomedical and Molecular Sciences, Queen’s University, Kingston, ON, CanadaFondazione Policlinico Universitario A. Gemelli IRCCS, Roma, ItalyDepartment of Clinical and Experimental Medicine, Unit of Endocrinology, University of Pisa, Pisa, ItalyDepartment of Clinical and Experimental Medicine, Unit of Endocrinology, University of Pisa, Pisa, ItalyFondazione Policlinico Universitario A. Gemelli IRCCS, Roma, ItalyFondazione Policlinico Universitario A. Gemelli IRCCS, Roma, ItalyDepartment of Clinical and Experimental Medicine, Unit of Endocrinology, University of Pisa, Pisa, ItalyDepartment of Biomedical and Molecular Sciences, Queen’s University, Kingston, ON, CanadaDepartment of Clinical and Experimental Medicine, Unit of Endocrinology, University of Pisa, Pisa, ItalyIntroduction. Loss of function mutations of CYP24A1 gene, which is involved in vitamin D catabolism, cause vitamin D-mediated PTH-independent hypercalcemia. The phenotype varies from life-threatening forms in the infancy to milder forms in the adulthood. Case Presentation. We report a case of a 17-year-old woman with a history of nephrolithiasis, mild PTH-independent hypercalcemia (10,5mg/dL), and high serum 1,25(OH)2D concentrations (107pg/mL). Other causes of hypercalcemia associated with the above biochemical signature were excluded. Family history revealed nephrolithiasis in the sister. Blood testing in first-degree relatives showed serum PTH in the low-normal range and 1,25(OH)2D at the upper normal limit or slightly elevated. The CYP24A1 gene analysis revealed a known homozygous loss-of-function pathogenic variant (c.428_430delAAG, rs777676129, p.Glu143del). The panel of vitamin D metabolites evaluated by liquid chromatography showed the typical profile of CYP24A1 mutations, namely, low 24,25(OH)2D3, elevated 25(OH)D3:24,25(OH)2D3 ratio, and undetectable 1,24,25(OH)3D3. The parents and both the siblings harbored the same variant in heterozygosis. We decided for a watchful waiting approach and the patient remained clinically and biochemically stable over a 24-month followup. Conclusion. CYP24A1 gene mutations should be considered in cases of PTH-independent hypercalcemia, once that more common causes (hypercalcemia of malignancy, granulomatous diseases, and vitamin D intoxication) have been ruled out.http://dx.doi.org/10.1155/2019/4982621 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Daniele Cappellani Alessandro Brancatella Martin Kaufmann Angelo Minucci Edda Vignali Domenico Canale Elisa De Paolis Ettore Capoluongo Filomena Cetani Glenville Jones Claudio Marcocci |
spellingShingle |
Daniele Cappellani Alessandro Brancatella Martin Kaufmann Angelo Minucci Edda Vignali Domenico Canale Elisa De Paolis Ettore Capoluongo Filomena Cetani Glenville Jones Claudio Marcocci Hereditary Hypercalcemia Caused by a Homozygous Pathogenic Variant in the CYP24A1 Gene: A Case Report and Review of the Literature Case Reports in Endocrinology |
author_facet |
Daniele Cappellani Alessandro Brancatella Martin Kaufmann Angelo Minucci Edda Vignali Domenico Canale Elisa De Paolis Ettore Capoluongo Filomena Cetani Glenville Jones Claudio Marcocci |
author_sort |
Daniele Cappellani |
title |
Hereditary Hypercalcemia Caused by a Homozygous Pathogenic Variant in the CYP24A1 Gene: A Case Report and Review of the Literature |
title_short |
Hereditary Hypercalcemia Caused by a Homozygous Pathogenic Variant in the CYP24A1 Gene: A Case Report and Review of the Literature |
title_full |
Hereditary Hypercalcemia Caused by a Homozygous Pathogenic Variant in the CYP24A1 Gene: A Case Report and Review of the Literature |
title_fullStr |
Hereditary Hypercalcemia Caused by a Homozygous Pathogenic Variant in the CYP24A1 Gene: A Case Report and Review of the Literature |
title_full_unstemmed |
Hereditary Hypercalcemia Caused by a Homozygous Pathogenic Variant in the CYP24A1 Gene: A Case Report and Review of the Literature |
title_sort |
hereditary hypercalcemia caused by a homozygous pathogenic variant in the cyp24a1 gene: a case report and review of the literature |
publisher |
Hindawi Limited |
series |
Case Reports in Endocrinology |
issn |
2090-6501 2090-651X |
publishDate |
2019-01-01 |
description |
Introduction. Loss of function mutations of CYP24A1 gene, which is involved in vitamin D catabolism, cause vitamin D-mediated PTH-independent hypercalcemia. The phenotype varies from life-threatening forms in the infancy to milder forms in the adulthood. Case Presentation. We report a case of a 17-year-old woman with a history of nephrolithiasis, mild PTH-independent hypercalcemia (10,5mg/dL), and high serum 1,25(OH)2D concentrations (107pg/mL). Other causes of hypercalcemia associated with the above biochemical signature were excluded. Family history revealed nephrolithiasis in the sister. Blood testing in first-degree relatives showed serum PTH in the low-normal range and 1,25(OH)2D at the upper normal limit or slightly elevated. The CYP24A1 gene analysis revealed a known homozygous loss-of-function pathogenic variant (c.428_430delAAG, rs777676129, p.Glu143del). The panel of vitamin D metabolites evaluated by liquid chromatography showed the typical profile of CYP24A1 mutations, namely, low 24,25(OH)2D3, elevated 25(OH)D3:24,25(OH)2D3 ratio, and undetectable 1,24,25(OH)3D3. The parents and both the siblings harbored the same variant in heterozygosis. We decided for a watchful waiting approach and the patient remained clinically and biochemically stable over a 24-month followup. Conclusion. CYP24A1 gene mutations should be considered in cases of PTH-independent hypercalcemia, once that more common causes (hypercalcemia of malignancy, granulomatous diseases, and vitamin D intoxication) have been ruled out. |
url |
http://dx.doi.org/10.1155/2019/4982621 |
work_keys_str_mv |
AT danielecappellani hereditaryhypercalcemiacausedbyahomozygouspathogenicvariantinthecyp24a1geneacasereportandreviewoftheliterature AT alessandrobrancatella hereditaryhypercalcemiacausedbyahomozygouspathogenicvariantinthecyp24a1geneacasereportandreviewoftheliterature AT martinkaufmann hereditaryhypercalcemiacausedbyahomozygouspathogenicvariantinthecyp24a1geneacasereportandreviewoftheliterature AT angelominucci hereditaryhypercalcemiacausedbyahomozygouspathogenicvariantinthecyp24a1geneacasereportandreviewoftheliterature AT eddavignali hereditaryhypercalcemiacausedbyahomozygouspathogenicvariantinthecyp24a1geneacasereportandreviewoftheliterature AT domenicocanale hereditaryhypercalcemiacausedbyahomozygouspathogenicvariantinthecyp24a1geneacasereportandreviewoftheliterature AT elisadepaolis hereditaryhypercalcemiacausedbyahomozygouspathogenicvariantinthecyp24a1geneacasereportandreviewoftheliterature AT ettorecapoluongo hereditaryhypercalcemiacausedbyahomozygouspathogenicvariantinthecyp24a1geneacasereportandreviewoftheliterature AT filomenacetani hereditaryhypercalcemiacausedbyahomozygouspathogenicvariantinthecyp24a1geneacasereportandreviewoftheliterature AT glenvillejones hereditaryhypercalcemiacausedbyahomozygouspathogenicvariantinthecyp24a1geneacasereportandreviewoftheliterature AT claudiomarcocci hereditaryhypercalcemiacausedbyahomozygouspathogenicvariantinthecyp24a1geneacasereportandreviewoftheliterature |
_version_ |
1725885102744928256 |